hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells

Cell Mol Life Sci. 2020 Nov;77(21):4413-4428. doi: 10.1007/s00018-019-03425-6. Epub 2020 Jan 2.

Abstract

The chemotherapeutic drug epirubicin increases the exosomal export of miR-503 in endothelial cells. To understand the mechanisms behind this process, we transfected endothelial cells with miR-503 carrying a biotin tag. Then, we pulled-down the proteins interacting with miR-503 and studied their role in microRNA exosomal export. A total of four different binding partners were identified by mass spectrometry and validated by western blotting and negative controls, among them ANXA2 and hnRNPA2B1. Using knock-down systems combined with pull-down analysis, we determined that epirubicin mediates the export of miR-503 by disrupting the interaction between hnRNPA2B1 and miR-503. Then, both ANXA2 and miR-503 are sorted into exosomes while hnRNPA2B1 is relocated into the nucleus. The combination of these processes culminates in the increased export of miR-503. These results suggest, for the first time, that RNA-binding proteins can negatively regulate the exosomal sorting of microRNAs.

Keywords: EVs; Exosomal export; Exosomes; MicroRNAs; RNA-binding proteins.

MeSH terms

  • Annexin A2 / metabolism
  • Endothelial Cells / metabolism*
  • Exosomes / metabolism*
  • Heterogeneous-Nuclear Ribonucleoprotein Group A-B / metabolism*
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • MicroRNAs / metabolism*
  • RNA Transport

Substances

  • ANXA2 protein, human
  • Annexin A2
  • Heterogeneous-Nuclear Ribonucleoprotein Group A-B
  • MIRN503 microRNA, human
  • MicroRNAs
  • hnRNP A2